Cargando…
Growth factor purification and delivery systems (PADS) for therapeutic angiogenesis
BACKGROUND: Therapeutic angiogenesis with vascular endothelial growth factor (VEGF), delivered either via recombinant protein infusion or via gene therapy, has shown promise in preclinical models of various diseases including myocardial infarction, renovascular disease, preeclampsia, and neurodegene...
Autores principales: | George, Eric M, Liu, Huiling, Robinson, Grant G, Mahdi, Fakhri, Perkins, Eddie, Bidwell, Gene L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316602/ https://www.ncbi.nlm.nih.gov/pubmed/25653833 http://dx.doi.org/10.1186/s13221-014-0026-3 |
Ejemplares similares
-
A Maternally Sequestered, Biopolymer‐Stabilized Vascular Endothelial Growth Factor (VEGF) Chimera for Treatment of Preeclampsia
por: Logue, Omar C., et al.
Publicado: (2017) -
Molecular Size Modulates Pharmacokinetics, Biodistribution, and Renal Deposition of the Drug Delivery Biopolymer Elastin-like Polypeptide
por: Kuna, Marija, et al.
Publicado: (2018) -
Utilizing a Kidney-Targeting Peptide to Improve Renal Deposition of a Pro-Angiogenic Protein Biopolymer
por: Mahdi, Fakhri, et al.
Publicado: (2019) -
Elastin-like polypeptide delivery of anti-inflammatory peptides to the brain following ischemic stroke
por: Howell, John Aaron, et al.
Publicado: (2023) -
Thermally Targeted Delivery of a c-Myc Inhibitory Polypeptide Inhibits Tumor Progression and Extends Survival in a Rat Glioma Model
por: Bidwell, Gene L., et al.
Publicado: (2013)